-
Dr. Reddy’s inks strategic deal for 8 injectables with Gland Pharma
HYDERABAD, INDIA and PRINCETON, N.J. — Dr. Reddy’s Laboratories and Gland Pharma have announced a strategic collaboration to market and distribute eight injectable generics.The portfolio includes hospital- and clinic-administered products for which abbreviated new drug applications (ANDAs) have been filed, and some whose ANDAs will be filed imminently, the companies said. The combined U.S. sales of the drugs for 12 months ending August 2016 were about $1 billion, according to IMS Health moving annual total data. -
Kaléo’s Auvi-Q auto-injector to return to U.S. in 2017
RICHMOND, Va. — Kaléo announced Wednesday that it will be reintroducing its Auvi-Q (epinephrine injection) auto-injector in the United States during the first half of 2017. This would bring another option to the epinephrine auto-injector space at a time when access and affordability in the space have seen focus from patients and legislators.